531 related articles for article (PubMed ID: 20082463)
21. Germline VHL gene mutations in three Serbian families with von Hippel-Lindau disease.
Stanojevic BR; Lohse P; Neskovic GG; Damjanovic SM; Novkovic TB; Jovanovic-Cupic SP; Dimitrijević BB
Neoplasma; 2007; 54(5):402-6. PubMed ID: 17688370
[TBL] [Abstract][Full Text] [Related]
22. Von Hippel-Lindau syndrome. A pleomorphic condition.
Friedrich CA
Cancer; 1999 Dec; 86(11 Suppl):2478-82. PubMed ID: 10630173
[TBL] [Abstract][Full Text] [Related]
23. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
[TBL] [Abstract][Full Text] [Related]
24. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene.
Richards FM; Payne SJ; Zbar B; Affara NA; Ferguson-Smith MA; Maher ER
Hum Mol Genet; 1995 Nov; 4(11):2139-43. PubMed ID: 8589692
[TBL] [Abstract][Full Text] [Related]
25. A novel mutation links to von Hippel-Lindau syndrome in a Chinese family with hemangioblastoma.
Fu XM; Zhao SL; Gui JC; Jiang YQ; Shen MN; Su DL; Gu BJ; Wang XQ; Ren QJ; Yin XD; Huang WB; Chen XG
Genet Mol Res; 2015 May; 14(2):4513-20. PubMed ID: 25966224
[TBL] [Abstract][Full Text] [Related]
26. [Endolymphatic sac tumor with von Hippel-Lindau disease: report of two cases with testing of von Hippel-Lindau gene].
Su Y; Shen WD; Wang CC; Han WJ; Liu J; Hou ZH; Song ZG; Huang DL; Han DY; Yang SM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Nov; 48(11):913-8. PubMed ID: 24444636
[TBL] [Abstract][Full Text] [Related]
27. Von Hippel-Lindau (VHL) disease: an update on the clinico-pathologic and genetic aspects.
Shehata BM; Stockwell CA; Castellano-Sanchez AA; Setzer S; Schmotzer CL; Robinson H
Adv Anat Pathol; 2008 May; 15(3):165-71. PubMed ID: 18434768
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetic analysis of von Hippel-Lindau disease.
Richards FM; Webster AR; McMahon R; Woodward ER; Rose S; Maher ER
J Intern Med; 1998 Jun; 243(6):527-33. PubMed ID: 9681854
[TBL] [Abstract][Full Text] [Related]
29. Consequences of direct genetic testing for germline mutations in the clinical management of families with multiple endocrine neoplasia, type II.
Neumann HP; Eng C; Mulligan LM; Glavac D; Zäuner I; Ponder BA; Crossey PA; Maher ER; Brauch H
JAMA; 1995 Oct; 274(14):1149-51. PubMed ID: 7563486
[TBL] [Abstract][Full Text] [Related]
30. [Von Hippel-Lindau syndrome - two sides of the same coin].
Páleníková P; Adamcová M; Šturdík I; Ftáčniková B; Copáková L; Payer J
Vnitr Lek; 2016; 62(12):1004-1008. PubMed ID: 28139130
[TBL] [Abstract][Full Text] [Related]
31. The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.
Gläsker S; Bender BU; Apel TW; Natt E; van Velthoven V; Scheremet R; Zentner J; Neumann HP
J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):758-62. PubMed ID: 10567493
[TBL] [Abstract][Full Text] [Related]
32. Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor Registry.
Bausch B; Wellner U; Peyre M; Boedeker CC; Hes FJ; Anglani M; de Campos JM; Kanno H; Maher ER; Krauss T; Sansó G; Barontini M; Letizia C; Hader C; Schiavi F; Zanoletti E; Suárez C; Offergeld C; Malinoc A; Zschiedrich S; Glasker S; Bobin S; Sterkers O; Ba Huy PT; Giraud S; Links T; Eng C; Opocher G; Richard S; Neumann HP;
Head Neck; 2016 Apr; 38 Suppl 1():E673-9. PubMed ID: 25867206
[TBL] [Abstract][Full Text] [Related]
33. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors.
Prowse AH; Webster AR; Richards FM; Richard S; Olschwang S; Resche F; Affara NA; Maher ER
Am J Hum Genet; 1997 Apr; 60(4):765-71. PubMed ID: 9106522
[TBL] [Abstract][Full Text] [Related]
34. [Familial and genetic study in a large Chinese kindred with von Hippel-Lindau disease and gene mutation analysis].
Zhang J; Huang YR; Wang JD; Fan XD
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):5-9. PubMed ID: 14767899
[TBL] [Abstract][Full Text] [Related]
35. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma.
Lee JS; Lee JH; Lee KE; Kim JH; Hong JM; Ra EK; Seo SH; Lee SJ; Kim MJ; Park SS; Seong MW
BMC Med Genet; 2016 Jul; 17(1):48. PubMed ID: 27439424
[TBL] [Abstract][Full Text] [Related]
36. Familial neurogenic tumor syndromes.
Kimmelman A; Liang BC
Hematol Oncol Clin North Am; 2001 Dec; 15(6):1073-84. PubMed ID: 11770299
[TBL] [Abstract][Full Text] [Related]
37. A Novel von Hippel Lindau Gene Intronic Variant and Its Reclassification from VUS to Pathogenic: the Impact on a Large Family.
Sexton A; Rawlings L; McKavanagh G; Simons K; Winship I
J Genet Couns; 2015 Dec; 24(6):882-9. PubMed ID: 26323595
[TBL] [Abstract][Full Text] [Related]
38. Genotype-phenotype correlations, and retinal function and structure in von Hippel-Lindau disease.
Wittström E; Nordling M; Andréasson S
Ophthalmic Genet; 2014 Jun; 35(2):91-106. PubMed ID: 24555745
[TBL] [Abstract][Full Text] [Related]
39. Update on the management of familial central nervous system tumor syndromes.
Hottinger AF; Khakoo Y
Curr Neurol Neurosci Rep; 2007 May; 7(3):200-7. PubMed ID: 17488585
[TBL] [Abstract][Full Text] [Related]
40. Novel human pathological mutations. Gene symbol: VHL. Disease: Von Hippel-Lindau syndrome.
Castellano M
Hum Genet; 2009 Aug; 126(2):340. PubMed ID: 19694021
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
